MBNL1 and myotonic dystrophy type 1: As mentioned previously, the most effective PMOs (i.e., with lower EC50 values, those conjugated to 9b2 and 9b2KC) outperformed 6aKC PMOs, correcting molecular alterations like Mbnl1 mRNA/protein levels and characteristic missplicing events in DM1.